Miriam Kuppermann

Dr. Miriam Kuppermann


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Patient Education and Counseling
Verified
Journal Article
Closed access
CDChristine Dehlendorf
Christine Dehlendorf
JFJudith Fitzpatrick
Judith Fitzpatrick
JSJody Steinauer
Jody Steinauer
LSLawrence Swiader
Lawrence Swiader
KGKevin Grumbach
Kevin Grumbach
MKMiriam Kuppermann
Miriam Kuppermann

1 February 2015 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
KHKathryn A. Houston
Kathryn A. Houston
AKAnjali J. Kaimal
Anjali J. Kaimal
SNSanae Nakagawa
Sanae Nakagawa
SGSteven E. Gregorich
Steven E. Gregorich
LYLynn M. Yee
Lynn M. Yee
MKMiriam Kuppermann
Miriam Kuppermann

2 June 2020 in JAMA
Verified
Journal Article
Open access
PDF file
MKMiriam Kuppermann
Miriam Kuppermann
AKAnjali J. Kaimal
Anjali J. Kaimal
CBCinthia Blat
Cinthia Blat
JGJuan Gonzalez
Juan Gonzalez
MTMari-Paule Thiet
Mari-Paule Thiet
WGWilliam A. Grobman
William A. Grobman
Quiz Ref ID The US cesarean delivery rate increased from 20.7% in 19961 to 31.9% in 2018,2 accompanied by substantial increases in maternal morbidity.3,4 Safely decreasing the cesarean delivery rate is therefore an important public health goal.5 Part of the increased cesarean delivery rate is attributable to the decreased frequency with which women undergo trial of labor after previous cesarean delivery, which caused rates of vaginal birth after cesarean delivery to decrease from 28.3% in 19961 to 13.3% in 2018.2 Numerous factors have been posited as contributing to this decline, including the decreased number of hospitals and clinicians willing to offer trial of labor after cesarean.6 However, even when available, the proportion of women who undergo this delivery approach has decreased.7

1 October 2018 in Patient Education and Counseling
Verified
Journal Article
Closed access
JKJennifer L. Kerns
Jennifer L. Kerns
ALAlexis Light
Alexis Light
VDVanessa Dalton
Vanessa Dalton
BMBlair McNamara
Blair McNamara
JSJody Steinauer
Jody Steinauer
MKMiriam Kuppermann
Miriam Kuppermann

1 November 2014 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
VJVanessa L. Jacoby
Vanessa L. Jacoby
AJAlison Jacoby
Alison Jacoby
LLLee A. Learman
Lee A. Learman
MSMichael Schembri
Michael Schembri
SGSteven E. Gregorich
Steven E. Gregorich
MKMiriam Kuppermann
Miriam Kuppermann

4 March 2016 in Prenatal Diagnosis
Verified
Journal Article
Open access
PDF file
MKMiriam Kuppermann
Miriam Kuppermann
MNMary E. Norton
Mary E. Norton
KTKao Thao
Kao Thao
AOAllison O'Leary
Allison O'Leary
ONOnouwem Nseyo
Onouwem Nseyo
AKAnjali J. Kaimal
Anjali J. Kaimal
Objectives To compare utilities for prenatal testing outcomes among women inclined to continue their pregnancy despite abnormal results versus those inclined to terminate and to analyze how differences affect optimal prenatal testing strategies. Method Time tradeoff utilities for 23 outcomes were elicited from 281 women. We compared utilities based on termination inclination and applied them to a decision-analytic framework. Results Of participants, 46.6% indicated that they would ‘definitely’ or ‘probably’ continue their pregnancy despite results indicating an intellectual disability. These women assigned higher utilities to abnormal testing results and having a child with an intellectual disability than women who would probably or definitely terminate. Primary cell-free DNA screening had the most quality-adjusted life years for women inclined to continue their pregnancy but yielded an incremental cost-effectiveness ratio (ICER) of $1 685 449. Multiple marker screening with either cell-free DNA or diagnostic testing as follow-up had an ICER of $9037. Primary diagnostic testing resulted in the most quality-adjusted life years for women inclined to terminate, with an ICER of $111 776. Conclusion Women seeking testing vary in prenatal testing outcome preferences and termination inclinations in the context of results indicating an intellectual disability. How they envision utilizing prenatal testing information impacts their optimal testing strategy. © 2016 John Wiley & Sons, Ltd.